Review of QSAR for DNA Polymerase Inhibitors and New Models for Heterogeneous Series of Compounds

Publisher： Bentham Science Publishers

E-ISSN： 1875-6697|7|4|249-254

ISSN： 1573-4099

Source： Current Computer - Aided Drug Design, Vol.7, Iss.4, 2011-12, pp. : 249-254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

3D-QSAR Studies on a Series of Inhibitors Docked into a New Homology Model of the DNA-PK Receptor

By  

Current Pharmaceutical Design, Vol. 15, Iss. 32, 2009-11 ,pp. : 3796-3825

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR and Molecular Modeling Studies on a Series of Indole-based Pyridone Analogues as HCV NS5B Polymerase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 8, 2016-10 ,pp. : 757-770

Bentham Science Publishers

Access to resources Recommend Favorite

Comparative QSAR Studies on the Novel Series of Thiazolones and Tetrazole Derivatives as HCV NS5B Polymerase Allosteric Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 4, 2009-06 ,pp. : 286-297

Bentham Science Publishers

Access to resources Recommend Favorite

3D-QSAR and Docking Studies on a Series of Benzothiadiazine Derivatives as Genotype 1 HCV Polymerase Inhibitors

By  

Medicinal Chemistry, Vol. 8, Iss. 6, 2012-11 ,pp. : 1099-1107

Bentham Science Publishers

Access to resources Recommend Favorite

Design of Some New Potent Beta-secretase Inhibitors Based on QSAR and Molecular Modeling Study on a Series of Hydroxyethylamine Derivatives

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 3, 2013-01 ,pp. : 253-265

Bentham Science Publishers

Access to resources Recommend Favorite